Selection of Useful Publications
Emmace personnel are productive in terms of publications. Below are publications
co-authored together with our collaborators and partners. Take a look. It is worth it!
Emmace Publications
iBCS: 4. Application of the Inhalation Biopharmaceutics Classification System to the Development of Orally Inhaled Drug Products
Ben Forbes, Per Bäckman, Antonio Cabal, Andy Clark, Carsten Ehrhardt, Jayne E. Hastedt*, Anthony J. Hickey, Guenther Hochhaus, Wenlei Jiang, Stavros Kassinos, Philip J. Kuehl, Bo Olsson, David Prime, Yoen-Ju Son, Simon Teague, Ulrika Tehler, and Jennifer Wylie
Molecular Pharmaceutics, March 13 2025.
doi/10.1021/acs.molpharmaceut.4c01534
Molecular 3D Characterisation of Drug Distribution and Mg-Stearate Coating on Lactose Carrier Particles by ToF-SIMS and XPS
Peter Sjövall, Marie Ernstsson, Denny Mahlin, Kyrre Thalberg. Surface and Interface Analysis, 25 February 2025,
doi.org/10.1002/sia.7385
New theory to explain the effect of lactose fines on the performance of adhesive mixtures for inhalation
Kyrre Thalberg. International Journal of Pharmaceutics, Volume 663, 30 September 2024, 124549.
doi.org/10.1016/j.ijpharm.2024.124549
Advancing nasal formulation characterization: Considerations toward a robust and precise method to determine the mass fraction below 10 μm in nasal products
Niklas Baltz, Jan Olof Svensson, Marcus Skogevall, Ann Ohlsson, Mårten Svensson, Regina Scherließ
Aerosol Science and Technology, Published online: 03 Sep 2024.
doi/full/10.1080/02786826.2024.2394593#abstract
Kyrre Thalberg, Love Ivarsson, Mårten Svensson, Peter Elfman, Ann Ohlsson, Jackie Stuckel, Ann-Marie Lyberg
European Journal of Pharmaceutical Sciences, Volume 193, 2024, 106679, ISSN 0928-0987
doi.org/10.1016/j.ejps.2023.106679
iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products
Jayne E. Hastedt, Per Bäckman, Antonio Cabal, Andy Clark, Carsten Ehrhardt, Ben Forbes, Anthony J. Hickey, Guenther Hochhaus, Wenlei Jiang, Stavros Kassinos, Philip J. Kuehl, David Prime, Yoen-Ju Son, Simon Teague, Ulrika Tehler, and Jennifer Wylie
Molecular Pharmaceutics Article ASAP
DOI: 10.1021/acs.molpharmaceut.3c00685
The match between adhesive mixture powder formulations for inhalation and the inhaler device
Kyrre Thalberg, Rasia Ahmadi, Jackie Stuckel, Peter Elfman, Mårten Svensson. European Journal of Pharmaceutical Sciences, Volume 186, 1 July 2023, 106457
https://www.sciencedirect.com/science/article/pii/S0928098723000878
Formulation development of adhesive mixtures for inhalation – A multi-factorial optimization challenge: Part 2
Thalberg K. Inhalation Mag, Aug 2022, https://www.e-digitaleditions.com/i/1475629-inh0822/23?
Formulation development of adhesive mixtures for inhalation – A multi-factorial optimization challenge: Part 1
Thalberg K. Inhalation Mag, June 2022, https://www.e-digitaleditions.com/i/1469783-inh0622/25?
The Effects of Inhalation Flow Rate on Aerodynamic Particle Size Distribution of Commercial Solution and Suspension Metered Dose Inhalers
Mohan AR, Dhapare S, Newman B, Svensson M, Elfman P, Winner L, Bulitta JB, Hochhaus G.
Respiratory Drug Delivery 2022. Volume 1, 2022: 417-422.
Effects of Formulation and Actuator Design on Spray Velocity of Mometasone Furoate Metered Dose Inhalers
Dhapare S, Murphy SD, Sandell D, Winner L, Sheth P, Hallinger M, Svensson M, Conti DS, Oguntimein O, Bulitta JB, Hochhaus G.
Respiratory Drug Delivery 2022. Volume 1, 2022: 411-416.
iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes
Per Bäckman, Antonio Cabal, Andy Clark, Carsten Ehrhardt, Ben Forbes, Jayne Hastedt, Anthony Hickey, Guenther Hochhaus, Wenlei Jiang, Stavros Kassinos, Philip J. Kuehl, David Prime, Yoen-Ju Son, Simon P. Teague, Ulrika Tehler, and Jennifer Wylie
Molecular Pharmaceutics Article ASAP
DOI: 10.1021/acs.molpharmaceut.2c00112
iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System
Jayne E. Hastedt, Per Bäckman, Antonio Cabal, Andy Clark, Carsten Ehrhardt, Ben Forbes, Anthony J. Hickey, Guenther Hochhaus, Wenlei Jiang, Stavros Kassinos, Philip J. Kuehl, David Prime, Yoen-Ju Son, Simon Teague, Ulrika Tehler, and Jennifer Wylie
Molecular Pharmaceutics Article ASAP
DOI: 10.1021/acs.molpharmaceut.2c00113
Systematic Evaluation of the Effect of Formulation Variables on In Vitro Performance of Mometasone Furoate Suspension-Metered Dose Inhalers
Bachhav SS, Sheth P, Sandell D, Svensson M, Bhagwat S, Conti DS, Oguntimein O, Dhapare S, Saluja B, Winner L, Bulitta JB, Hochhaus G. AAPS J. 2021 Dec 7;24(1):9. doi: 10.1208/s12248-021-00638-1.
Factors Influencing Plume Characteristics of Metered Dose Inhalers (MDIs) Following passage through Bio-relevant throat models
S. Dhapare, B. Newman, M. Svensson, P. Elfman, D. Sandell, L. Winner, JB Bulitta, G. Hochhaus. Respiratory Drug Delivery 2021. Volume 1, 2021: 301-306.
AH de Boer, K Thalberg. Chapter 3: Devices and formulations: general introduction and wet aerosol delivery systems. In Inhaled Medicines: Optimizing Development Through Integration of In Silico, In Vitro and In Vivo Approaches (Eds. Hickey AJ, Kassinos S, Bäckman P, Conway J). Elsevier (academic Press Inc), 2021a ISBN-13: 9780128149744
AH de Boer, K Thalberg. Chapter 4: Metered Dose Inhalers (MDIs). In Inhaled Medicines: Optimizing Development Through Integration of In Silico, In Vitro and In Vivo Approaches (Eds. Hickey AJ, Kassinos S, Bäckman P, Conway J). Elsevier (academic Press Inc), 2021b ISBN-13: 9780128149744
AH de Boer, K Thalberg. Chapter 5: Dry Powder Inhalers (DPIs). In Inhaled Medicines: Optimizing Development Through Integration of In Silico, In Vitro and In Vivo Approaches (Eds. Hickey AJ, Kassinos S, Bäckman P, Conway J). Elsevier (academic Press Inc), 2021c ISBN-13: 9780128149744
B Olsson, H Lundbäck, M Svensson. Chapter 6: In vitro methods to study dose deposition. In Inhaled Medicines: Optimizing Development Through Integration of In Silico, In Vitro and In Vivo Approaches (Eds. Hickey AJ, Kassinos S, Bäckman P, Conway J). Elsevier (academic Press Inc), 2021 ISBN-13: 9780128149744
A Himstedt, P Bäckman, JM Borghardt. Chapter 12: Physiology-based pharmacokinetic modelling after drug inhalation. In Inhaled Medicines: Optimizing Development Through Integration of In Silico, In Vitro and In Vivo Approaches (Eds. Hickey AJ, Kassinos S, Bäckman P, Conway J). Elsevier (academic Press Inc), 2021 ISBN-13: 9780128149744
J Mitchell, D L Roberts, M Svensson, Resolving a few misconceptions when analyzing data from inhaler particle size distribution measurements, Inhalation April 2021. https://inhalation.mydigitalpublication.com/publication/?m=61975&i=702030&p=12
B Olsson and SC Kassinos, On the Validation of Generational Lung Deposition Computer Models Using Planar Scintigraphic Images: The Case of Mimetikos Preludium, J Aerosol Med Pulm Drug Deliv.2020; Ahead of print: https://doi-org.ludwig.lub.lu.se/10.1089/jamp.2020.1620
P Bäckman and B Olsson, Pulmonary Drug Dissolution, Regional Retention & Systemic Absorption: Understanding their Interactions Through Mechanistic Modeling, in Respiratory Drug Delivery 2020
PG Koullapis, FS Stylianou, J Sznitman, B Olsson and SC Kassinos, Towards whole-lung simulations of aerosol deposition: A model of the deep lung, J Aerosol Sci. 2020; 144 105541,https://doi.org/10.1016/j.jaerosci.2020.105541
Coating Stages of Next Generation Impactor (NGI) When Testing Metered Dose Inhalers (MDIs) A Comparative Study on US Commercial MDI Products
Sandell D, Svensson M, Conti DS, Sheth P, Oguntimein O, Bielski E, Bulitta JB, Hochhaus G. Respiratory Drug Delivery 2020. Volume 2, 2020: 463-468.
Effects of Formulation and Actuator Design on Spray Pattern and Plume Geometry of Mometasone Furoate Metered Dose Inhalers
Dhapare S, Bielski E, Conti DS, Oguntimein O, Sheth P, Hallinger M, Svensson M, Sandell D, Bulitta JB, Hochhaus G. Respiratory Drug Delivery 2020. Volume 3, 2020: 503-508.
The Effects of Formulation Factors and Actuator Design on Mometasone Furoate Metered Dose Inhaler In Vitro Aerosolization Performance
Bielski E, Conti DS, Oguntimein O, Sheth P, Hallinger M, Svensson M, Sandell D, Bulitta JB, Hochhaus G Respiratory Drug Delivery 2020. Volume 3, 2020: 497-502.
Nicholas, M., Josefsson, M., Fransson, M., Thalberg, K., Wilbs, J., Roos, C., Boissier, C., 2020. Quantification of surface concentration and surface structure of inhalation powders using TOF-SIMS. International Journal of Pharmaceutics 587, 119666.
Thalberg, K., Papathanasiou, F., Fransson, M., Nicholas, M., 2020. Controlling the performance of adhesive mixtures for inhalation using mixing energy. International Journal of Pharmaceutics 120055.
PG Koullapis, B Olsson, SC Kassinos and J Sznitman, Multiscale in silico lung modeling strategies for aerosol inhalation therapy and drug delivery, Curr Opin Biomed Eng. 2019; 11(September): 130-136
B Olsson and P Bäckman, Mimetikos PreludiumTM: A New Pharma-friendly Aerosol Drug Deposition Calculator, in Respiratory Drug Delivery 2018 (Eds. RN Dalby, PR Byron, D Traini, SJ Farr, JD Suman and A Watts), ISBN 978-1-942911-25-8, Virginia Commonwealth University, 2018, p 103-111
P Bäckman and B Olsson, De-risking Inhalation Product Development using Predictive Models in “Respiratory Drug Delivery Asia 2018”
P Bäckman, S Arora, W Couet, B Forbes, W de Kruijf, A Paudel. Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs. Eur J Pharm Sci. 2018 Feb 15;113:41-52. doi: 10.1016/j.ejps.2017.10.030.
Estimation of Stage Cut-offs for the Next Generation Impactor When Used at Flow Rates Above 100 L/min
Sandell D, Svensson M, Sandell K, Olsson A Respiratory Drug Delivery 2018. Volume 2, 2018: 513-518.
J Eriksson, E Sjögren, H Thörn, K Rubin, P Bäckman, H Lennerns. Pulmonary absorption – estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex-vivo rat model and computational analysis, Eur J Pharm Biopharm. 2018 Mar; 124:1-12.
Nguyen, D., Remmelgas, J., Niklasson Björn, I., van Wachem, B., Thalberg, K, 2018. Towards quantitative prediction of the performance of dry powder inhalers by multi-scale simulations and experiments. International Journal of Pharmaceutics 547, 31-43.
Pressurized Metered Dose Inhalers and the Slow Inhalation Recommendation
Asking L, Olsson B, Berg E, Svensson M Respiratory Drug Delivery 2018. Volume 2, 2018: 463-466.
D Sandell, B Olsson and L Borgström, PK bioequivalence testing when between-batch variability is high: A multiple.batch proposal, Inhalation magazine 2017, December issue.
Svensson M, Berg E, Mitchell J, Sandell D. Laboratory Study Comparing Pharmacopeial Testing of Nebulizers with Evaluation Based on Nephele Mixing Inlet Methodology. AAPS PharmSciTech. 2018 Feb;19(2):565-572. doi: 10.1208/s12249-017-0860-8. Epub 2017 Sep 5. PMID: 28875453.
Thalberg, K., Åslund, S., Skogevall, M., Andersson, P., 2016. Dispersibility of lactose fines as compared to API in dry powders for inhalation. International Journal of Pharmaceutics 504, 27-38.
Thalberg, K., Berg, E., Fransson, M., 2012. Modeling dispersion of dry powders for inhalation. The concepts of total fines, cohesive energy and interaction parameters. International Journal of Pharmaceutics 427, 224-233.
B Olsson, L Borgström, M Svensson and H Lundbäck, Validation of a General In Vitro Approach for Prediction of Total Lung Deposition in Healthy Adults for Pharmaceutical Inhalation Products, J Aerosol Med Pulm Drug Deliv. 2013; 23: 355-369
